Cargando…

Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experience

PURPOSE: Integrating magnetic resonance (MR) into radiotherapy planning has several advantages. This report details the clinical implementation of an MR simulation (MR-planning) program for external beam radiotherapy (EBRT) in one of North America's largest radiotherapy programs. METHODS AND MA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore-Palhares, Daniel, Ho, Ling, Lu, Lin, Chugh, Brige, Vesprini, Danny, Karam, Irene, Soliman, Hany, Symons, Sean, Leung, Eric, Loblaw, Andrew, Myrehaug, Sten, Stanisz, Greg, Sahgal, Arjun, Czarnota, Gregory J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903411/ https://www.ncbi.nlm.nih.gov/pubmed/36750891 http://dx.doi.org/10.1186/s13014-023-02209-4

Ejemplares similares

Quantitative MRI Biomarkers of Stereotactic Radiotherapy Outcome in Brain Metastasis
por: Karami, Elham, et al.
Publicado: (2019)

Quantitative Magnetization Transfer in Monitoring Glioblastoma (GBM) Response to Therapy
por: Mehrabian, Hatef, et al.
Publicado: (2018)

Investigation of irradiated volume in linac-based brain hypo-fractionated stereotactic radiotherapy
por: Ruschin, Mark, et al.
Publicado: (2017)

Novel MRI-guided focussed ultrasound stimulated microbubble radiation enhancement treatment for breast cancer
por: Dasgupta, Archya, et al.
Publicado: (2023)

Advanced Magnetic Resonance Imaging Techniques in Management of Brain Metastases
por: Mehrabian, Hatef, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

A FIRST REPORT ON OUTCOMES OF STEREOTACTIC BODY RADIOTHERAPY FOR POSTERIOR ELEMENT ONLY SPINAL METASTASES AND VALIDATION OF RECOMMENDED CLINICAL TARGET VOLUME DELINEATION PRACTICE
por: Burgess, Laura, et al.
Publicado: (2023)

Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy
por: Chang, Joe H., et al.
Publicado: (2016)

STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR SACRAL METASTASES: DEVIATION FROM RECOMMENDED TARGET VOLUME DELINEATION PREDICTS HIGHER RISK OF LOCAL FAILURE
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

Comparison of Prospectively Generated Glioma Treatment Plans Clinically Delivered on Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) Versus Conventional Linac: Predicted and Measured Skin Dose
por: Wang, Michael H., et al.
Publicado: (2022)

RE-IRRADIATION FOR RECURRENT HIGH-GRADE GLIOMA: AN ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL AND PREDICTORS OF RADIATION NECROSIS
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

30 GY IN 4 STEREOTACTIC BODY RADIOTHERAPY (SBRT) FRACTIONS FOR COMPLEX SPINAL METASTASES: MATURE OUTCOMES SUPPORTING THIS NOVEL REGIMEN
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

Chemical Exchange Saturation Transfer MRI: What Neuro-Oncology Clinicians Need To Know
por: Jabehdar Maralani, Pejman, et al.
Publicado: (2023)

Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy
por: Stewart, James, et al.
Publicado: (2023)

CLINICAL APPLICATION OF SATURATION TRANSFER MRI FOR DIFFERENTIATING TUMOUR PROGRESSION FROM RADIATION NECROSIS IN BRAIN METASTASES
por: Chan, Rachel W, et al.
Publicado: (2023)

LOCL-16 IMPACT OF MGMT PROMOTER METHYLATION STATUS ON TUMOR DYNAMICS DURING WEEKLY ADAPTIVE RADIOTHERAPY FOR GLIOBLASTOMA
por: Hudson, John M, et al.
Publicado: (2022)

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021)

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021)

Improved dosimetric accuracy with semi‐automatic contour propagation of organs‐at‐risk in glioblastoma patients undergoing chemoradiation
por: Lee, Sangjune, et al.
Publicado: (2019)

High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report
por: Tseng, Chia-Lin, et al.
Publicado: (2022)

Tissue segmentation‐based electron density mapping for MR‐only radiotherapy treatment planning of brain using conventional T1‐weighted MR images
por: Yu, Huan, et al.
Publicado: (2019)

BIOMARKER STATUS PREDICTS FOR LOCAL CONTROL (LC) FOLLOWING SPINE STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH SPINAL METASTASES
por: Shor, Dana, et al.
Publicado: (2023)

ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastoma
por: Maralani, Pejman Jabehdar, et al.
Publicado: (2021)

Spine Stereotactic Body Radiotherapy: Indications, Outcomes, and Points of Caution
por: Tseng, Chia-Lin, et al.
Publicado: (2017)

Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma
por: Maralani, Pejman Jabehdar, et al.
Publicado: (2021)

Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
por: Soliman, Hany, et al.
Publicado: (2016)

A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning
por: Jaberipour, Majid, et al.
Publicado: (2021)

Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow
por: Tseng, Chia-Lin, et al.
Publicado: (2020)

Impact of Tumour Segmentation Accuracy on Efficacy of Quantitative MRI Biomarkers of Radiotherapy Outcome in Brain Metastasis
por: Jalalifar, Seyed Ali, et al.
Publicado: (2022)

Predicting the outcome of radiotherapy in brain metastasis by integrating the clinical and MRI‐based deep learning features
por: Jalalifar, Seyed Ali, et al.
Publicado: (2022)

MOLECULAR PROFILING TO UNDERSTAND TREATMENT RESISTANCE AND RESPONSE IN GLIOBLASTOMA
por: Nikolopoulos, Marina, et al.
Publicado: (2023)

Safety of palbociclib concurrent with palliative pelvic radiotherapy: discussion of a case of increased toxicity and brief review of literature
por: Dasgupta, Archya, et al.
Publicado: (2020)

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T
por: Klein, Jonathan, et al.
Publicado: (2018)

BEVACIZUMAB FOR SYMPTOMATIC RADIATION NECROSIS IN BRAIN METASTASES: OUTCOMES FROM A SINGLE-CENTER RETROSPECTIVE ANALYSIS
por: Roberto, Katrina, et al.
Publicado: (2023)

PREDICTORS OF TUMOR DYNAMICS DURING A COURSE OF 30-FRACTION RADIOTHERAPY FOR GLIOBLASTOMA
por: Ong, W L, et al.
Publicado: (2023)

Evaluation of the Efficacy of Rotational Corrections for Standard-Fractionation Head and Neck Image-Guided Radiotherapy
por: Kung, Joseph S., et al.
Publicado: (2019)

Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort Analysis
por: Stewart, James, et al.
Publicado: (2022)

Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis
por: Klein, Jonathan, et al.
Publicado: (2019)

MRI texture features from tumor core and margin in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
por: Kolios, Christopher, et al.
Publicado: (2021)

A systematic review and meta-analysis of clinician-reported versus patient-reported outcomes of radiation dermatitis
por: Lam, Emily, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q9ikmfbef40bdeb5donnhtjl1r